Canaccord Genuity analyst Jason Mills weighed in with a few insights on IMRIS Inc (NASDAQ:IMRS), after the company reported fourth-quarter earnings that missed expectations, sending shares plunging 11 percent. …
Canaccord Genuity analyst Jason Mills came out today with a favorable report on Sunshine Heart Inc (NASDAQ:SSH), following the news that the company received unconditional …
In a research report issued today, Canaccord Genuity analyst Jason Mills assigned a Buy rating on Novadaq Technologies (NASDAQ:NVDQ) with a price target of …
In a research note published yesterday, Canaccord analyst Jason Mills reiterated a Buy rating on Sunshine Heart (NASDAQ:SSH) with a $10 price target. …
In a research note published Tuesday, Canaccord analyst Jason Mills maintained a Buy rating on STAAR Surgical Company (STAA) with a price target of $21.00, after STAA received a warning letter from FDA …
In a research note published Friday, Canaccord analyst Jason Mills maintained a Buy rating on Thoratec Corp. (THOR) with a price target of $37.
Canaccord analyst Jason Mills today upgraded his rating on AngioDynamics Inc. (ANGO) to Buy from Hold, and raised his price target to $20 from $16.
